K213875

Substantially Equivalent

DRI TM Tricyclics Serum Tox Assay

Applicant: Microgenics Corporation
Product code: LFH
Advisory panel: Clinical Toxicology
Date received: 2021-12-13
Decision date: 2022-12-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Fremont, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.